SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
------------------------------
FORM 8-K
CURRENT REPORT
Pursuant to Sections 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 7, 2003
-----------
FRESENIUS MEDICAL CARE HOLDINGS, INC.
--------------------------------------
(Exact name of registrant as specified in its charter)
New York
--------------------------------------------------
(State or other jurisdiction of incorporation)
1-3720 13-3461988
----------------------------------------------------------------------
(Commission File Number (IRS Employer Identification No.)
95 Hayden Avenue Lexington, Massachusetts 02420
----------------------------------------------------------------------
(Address or principal executive offices) (Zip Code)
Registrant's telephone number, including area codes: (781) 402-9000
--------------
Not Applicable
-------------------------------------------------------------
(Former name or former address, if changed since last report)
ITEM 7. Financial Statements and Exhibits
Exhibit 99.1 Press Release dated May 7, 2003, reporting the
Company's results of operations for the first quarter
ended March 31, 2003.
ITEM 9. REGULATION FD DISCLOSURE
This information set forth under "Item 9. Regulation FD Disclosure" is
intended to be furnished solely under "Item 12. Results Of Operations and
Financial Condition" in accordance with SEC Release No. 33-8216. Such
information, including the Exhibit attached hereto, shall not be deemed "filed"
for purposes of Section 18 of the Securities and Exchange Act of 1934 (the
"Exchange Act") or otherwise subject to the liabilities of that section, nor
shall it be deemed incorporated by reference in any filing under the Securities
Act of 1933 or the Exchange Act, regardless of any general incorporation
language in such filing.
On May 7, 2003, Fresenius Medical Care, AG (the "Company") issued a
press release announcing its earnings for the first quarter ended March 31,
2003. A copy of the press release is furnished as Exhibit 99.1.
ITEM 12. RESULTS OF OPERATIONS AND FINANCIAL CONDITION
The information required under this Item 12 is being provided under Item
9 of this report as provided in SEC Release No. 33-8216.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
FRESENIUS MEDICAL CARE HOLDINGS, INC.
/s/ Jerry Schneider
-------------------------------------
DATE: May 7, 2003 Name: Jerry Schneider
Title: Chief Financial Officer
2
s